Results 161 to 170 of about 117,738 (304)
Oral contraceptives exposure may reduce the risk of ovarian cancer: a meta-analysis based on cohort studies. [PDF]
Sun Q +5 more
europepmc +1 more source
Slowing the stork : better health for women through family planning [PDF]
Each year 500,000 women die from causes related to pregnancy - 99 percent of them in developing countries. While many of those pregnancies are unwanted and could have been prevented by family planning, only a minority of developing country couples use ...
Measham, Anthony R., Rochat, Roger W.
core
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
Exposure to oral contraceptives alters human endometrial stem cells culture media secretome. [PDF]
Rochetti RC +7 more
europepmc +1 more source
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study [PDF]
Alvarez, Enrique, Cross, Anne H, et al,
core +2 more sources
Development of the Zimbabwe family planning program [PDF]
Family planning was introduced in Zimbabwe as a voluntary movement in the 1950s. Volunteers formed a Family Planning Association in the mid-1960s. The government became interested in family planning in the late 1960s after analysis of the 1961 population
Zinanga, Alex F.
core
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
When Birth Control Turns Biliary: A Rare Case of Profound Hyperbilirubinemia From Oral Contraceptives. [PDF]
Ajani T +6 more
europepmc +1 more source
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin +7 more
wiley +1 more source

